BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36241221)

  • 1. Proportions and incidence of locally advanced cervical cancer: a global systematic literature review.
    Monk BJ; Tan DSP; Hernández Chagüi JD; Takyar J; Paskow MJ; Nunes AT; Pujade-Lauraine E
    Int J Gynecol Cancer; 2022 Dec; 32(12):1531-1539. PubMed ID: 36241221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
    Marnitz S; Tsunoda AT; Martus P; Vieira M; Affonso Junior RJ; Nunes J; Budach V; Hertel H; Mustea A; Sehouli J; Scharf JP; Ulrich U; Ebert A; Piwonski I; Kohler C
    Int J Gynecol Cancer; 2020 Dec; 30(12):1855-1861. PubMed ID: 33293284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding cervical cancer after the age of routine screening: Characteristics of cases, treatment, and survival in the United States.
    Lichter KE; Levinson K; Hammer A; Lippitt MH; Rositch AF
    Gynecol Oncol; 2022 Apr; 165(1):67-74. PubMed ID: 35115179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial.
    Köhler C; Mustea A; Marnitz S; Schneider A; Chiantera V; Ulrich U; Scharf JP; Martus P; Vieira MA; Tsunoda A
    Am J Obstet Gynecol; 2015 Oct; 213(4):503.e1-7. PubMed ID: 25986030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical Cancer Prevalence, Incidence and Mortality in Low and Middle Income Countries: A Systematic Review.
    Shrestha AD; Neupane D; Vedsted P; Kallestrup P
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):319-324. PubMed ID: 29479954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Quality Care and Mortality for Patients With Locally Advanced Cervical Cancer in Virginia.
    Showalter TN; Camacho F; Cantrell LA; Anderson RT
    Medicine (Baltimore); 2016 Feb; 95(8):e2913. PubMed ID: 26937934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored radical hysterectomy for locally advanced cervical cancer.
    Sakuragi N; Kaneuchi M; Kato T; Shimada C; Todo Y; Ihira K; Nozaki A; Umazume T; Konno Y; Mitamura T; Kobayashi N; Murakami G; Watari H
    Int J Gynecol Cancer; 2020 Aug; 30(8):1136-1142. PubMed ID: 32522774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy.
    Loverix L; Salihi RR; Van Nieuwenhuysen E; Concin N; Han S; van Gorp T; Vergote I
    Int J Gynecol Cancer; 2020 Apr; 30(4):466-472. PubMed ID: 32079714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer.
    Odunsi KO; Lele S; Ghamande S; Seago P; Driscoll DL
    Eur J Gynaecol Oncol; 2001; 22(5):325-30. PubMed ID: 11766731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis.
    Wu SG; Zhang WW; Sun JY; Li FY; He ZY; Zhou J
    Int J Surg; 2017 Dec; 48():122-127. PubMed ID: 29032160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study.
    Ryzhov A; Corbex M; Piñeros M; Barchuk A; Andreasyan D; Djanklich S; Ghervas V; Gretsova O; Kaidarova D; Kazanjan K; Mardanli F; Michailovich Y; Ten E; Yaumenenka A; Bray F; Znaor A
    Lancet Oncol; 2021 Mar; 22(3):361-369. PubMed ID: 33556324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions.
    Monk BJ; Tewari KS; Koh WJ
    J Clin Oncol; 2007 Jul; 25(20):2952-65. PubMed ID: 17617527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
    de Foucher T; Bendifallah S; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Monnier L; Graesslin O; Touboul C; Collinet P; Neveu ME; Huchon C; Daraï E; Ballester M;
    Eur J Surg Oncol; 2019 Apr; 45(4):659-665. PubMed ID: 30685326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Trend in proportion and clinicopathological characteristics of young women with stage Ⅰa2 to Ⅱa2 cervical cancer].
    Wang W; Hao M; Chen CL; Liu P; Ling B; Kang S; Lu AW; Wang WL; Zhao WD; Zhu QY; Zhao YY; Zhao HW; Jin SL; Ni Y; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):666-672. PubMed ID: 31648442
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
    Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
    Mori T; Makino H; Okubo T; Fujiwara Y; Sawada M; Kuroboshi H; Tsubamoto H; Murakoshi H; Motohashi T; Kitawaki J; Ito K
    J Obstet Gynaecol Res; 2019 Mar; 45(3):671-678. PubMed ID: 30575239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.